Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/07/2003WO2002055541A3 Peptides having inhibiting activity on the production of nitric oxide
08/07/2003WO2002051819A9 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
08/07/2003WO2002050288A9 Neocentromere-based mini-chromosomes or artificial chromosomes
08/07/2003WO2002049610A3 Ophthalmic irrigating solution adapted for use in lasik surgery
08/07/2003WO2002048150A3 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof
08/07/2003WO2002018608A9 Methods for enhancing the efficacy of cancer therapy
08/07/2003WO2002013867A3 Augmented cognitive training
08/07/2003WO2002009709A8 Method for reducing or eliminating smoking
08/07/2003WO2002002593A3 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
08/07/2003US20030149998 Nucleotide sequences coding orphan receptors/membrane proteins OM-10 and UP-11 for detecting modulators of inflammation, nervous system activity and infection; antitumor/antiinflammatory agents; gene expression inhibition
08/07/2003US20030149470 Radially expandable; coaxial polymer comprising pentafluoropropyl acrylate and (heptadecyl fluorodecyl methacrylate) comonomers
08/07/2003US20030149383 Patch containing anti-inflammatory agent
08/07/2003US20030149304 Formoterol tartrate polymorph
08/07/2003US20030149296 Such as 3-(4-salicyloylamino)phenoxypropionic acid; noncovalent drug delivery
08/07/2003US20030149294 Process for the preparation of latanoprost
08/07/2003US20030149288 Conjugated linoleic acid powder
08/07/2003US20030149287 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the NHE-inhibitory efficacy of compounds
08/07/2003US20030149277 Triarylimidazole derivatives as cytokine inhibitors
08/07/2003US20030149269 Substituted piperidine derivatives
08/07/2003US20030149268 Administering non-steroidal 9-pyrido(3,2-g)quinoline compounds to the mammal for affecting androgen receptor activity
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149253 Dehydroxylation; silylation; for accelerating activity of fibroblast growth factor
08/07/2003US20030149252 Efficient method for producing compositions enriched in total phenols
08/07/2003US20030149250 Labeled compounds useful in imaging amyloid deposits and useful for inhibiting the aggregation of amyloid protein to form amyloid deposit
08/07/2003US20030149236 Nucleotide sequences coding interleukin (IL)-11 receptor for development of agonists, antagonists, therapeutic and diagnostic reagents; antiproliferative/inflammatory agents
08/07/2003US20030149114 Antiviral agents
08/07/2003US20030149113 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
08/07/2003US20030149112 Enantiomers of O-desmethyl venlafaxine
08/07/2003US20030149111 For therapy of diabetes, hyperglycemia
08/07/2003US20030149110 For use as as neuro-protective agents for therapy of conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, anxiety, convulsions, aminoglycoside antibiotics-induced hearing loss, migraine
08/07/2003US20030149109 (E)-4-carboxystyrl-4-chlorobenzyl sulfone and pharmaceutical compositions thereof
08/07/2003US20030149108 Linked biaryl compounds
08/07/2003US20030149107 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
08/07/2003US20030149106 For use in moisturizing compositions (e.g., moisturizing skin treatments) to which medical adhesives will adhere, in tissue antiseptic preparations, in personal care forumulation such as cosmetics, and in drug delivery forumulations
08/07/2003US20030149104 Tri-substituted phenyl derivatives and analogues
08/07/2003US20030149102 Combining ascorbic acid and at least one partially or totally crosslinked, solid elastomeric organopolysiloxane
08/07/2003US20030149101 Administering combination of a cholesterol lowering drug and an angiotensin converting enzyme inhibitor for therapy of atherosclerosis
08/07/2003US20030149100 Clear micellized formulations of beta-carotene and method of treating leukoplakia
08/07/2003US20030149098 Clear micellized formulations of beta-carotene and method of treating leukoplakia
08/07/2003US20030149097 Storage-stable compositions of glycerol monoalkyl ethers
08/07/2003US20030149096 Administering a pharmaceutical formulation to a mammal to suppress initiation, promotion, or rogression of the multiple myeloma, formulation comprising active agent selected from the group consisting of brusatol, bruceantin, glaucarubolone
08/07/2003US20030149094 Compositions comprising ether compounds and pharmaceutical uses therefor
08/07/2003US20030149093 For therapy of dyspepsia, early satiety, bloating and anorexia
08/07/2003US20030149092 As antitumor agents
08/07/2003US20030149091 For therapy of inflammatory bowel disease, ulcerative colitis, pyoderma gangrenosum, Crohn's disease, irritable bowel syndrome, spastic dystonia, chronic pain, acute pain, celiac sprue, pouchitis, vasoconstriction, anxiety, panic disorder
08/07/2003US20030149090 Topically delivering an effective dose of a reactvie oxygen metabolites (ROM) production and release inhibitory compound in carrier to a subject suffering from ROM-mediated oxidative damage
08/07/2003US20030149089 Antibacterial compounds
08/07/2003US20030149088 Antiviral agent
08/07/2003US20030149087 For therapy of atherosclerosis, gallstone disease, lipid disorders, obesity or a cardiovascular disorder
08/07/2003US20030149086 EP4 receptor selective agonists in the treatment of osteoporosis
08/07/2003US20030149085 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
08/07/2003US20030149084 Cytostatic agents
08/07/2003US20030149082 Inhibiting transport of anandamide in an individual or animal comprising administering
08/07/2003US20030149081 For therapy and prophylaxis of asthma, seasonal and perennial allergic rhinitis, sinusitus, conjunctivitis, food allergy, scombroid poisoning, psoriasis, urticaria, pruritus, eczema, inflammatory bowel disease, atherosclerosis
08/07/2003US20030149076 Administering drug formulation comprising opioidergic agent and an insulin secretagogue for therapy of human suffering from one or more conditions included within Coronary Heart Disease Risk Factor Syndrome
08/07/2003US20030149075 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
08/07/2003US20030149073 Cycloalkano-indole and -azaindole derivatives
08/07/2003US20030149072 As anticancer agents, inhibitory activity on tubulin polymerization
08/07/2003US20030149071 Pyrido [2,1-a] isoquinoline derivatives
08/07/2003US20030149070 Method of treating cardiovascular disease
08/07/2003US20030149068 Use of chrysanthone A for the preparation of a medicament with antiangiogenic activity
08/07/2003US20030149067 Crystallisation of the desired crystalline form from a toluene/diethyl ether mixture comprising raw cabergoline, followed by recovery and drying of the resulting crystals
08/07/2003US20030149066 Administering nalbuphine or a prodrug of nalbuphine, and an opioid antagonist selected from the group consisting of naloxone, naltrexone, nalmefene, pharmaceutically acceptable salts thereof or prodrugs
08/07/2003US20030149065 Arylkylamine spirofuropyridines useful in therapy
08/07/2003US20030149064 Pyrimidine compounds
08/07/2003US20030149063 For therapy of ras- oncogene-dependent tumors, such as cancers of pancreas, colon, bladder, and thyroid; useful for controlling metastasis, suppressing angiogenesis, inducing apoptosis, and Ras-associated proliferative diseases
08/07/2003US20030149062 Therapy of inflammatory diseases of the airways or intestines which by administering substances selected from quinazoline derivatives, 4-((3-chloro-4-fluorophenyl)amino)-6-((4-dimethylamino-cyclohexyl)amino) -pyrimido(5,4-d)pyrimidine
08/07/2003US20030149061 Oily compositions containing highly fat-soluble drugs
08/07/2003US20030149058 Use of dipyridamole or mopidamol for treatment and prevention of fibrin-dependent microcirculation disorders
08/07/2003US20030149057 Anti-cancer compounds
08/07/2003US20030149056 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/07/2003US20030149055 Bicyclic compounds as inhibitors of chemokine binding to US28
08/07/2003US20030149054 Administering thiazolidinedione derivatives for therapy and prophylaxis of cardiovascular diseases or eating disorders in a human or non- human mammal
08/07/2003US20030149052 Side effect reduction
08/07/2003US20030149051 For therapy of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, cancer, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks
08/07/2003US20030149048 For therapy of hyperproliferative disorder in a mammal
08/07/2003US20030149047 Novel compounds
08/07/2003US20030149046 Pyrazoline derivative or tetrahydropyridazine derivative and medicinal use thereof
08/07/2003US20030149045 Therapy of graft versus host disease in a mammal by administering methotrexate and a quinazoline derivative
08/07/2003US20030149044 Succinic acid salts of 5,7,14-triazatetracyclo[10.1.02.11.04,9] -hexadeca-1(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149042 For prophylaxis and therapy of pain or nociception
08/07/2003US20030149040 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
08/07/2003US20030149039 For therapy of disease responsive to antagonist modulation of the Neurokinin-1 (NK-1) receptor in a patient
08/07/2003US20030149037 For therapy and prophylaxis of inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, neurodegenerative diseases, allergies, reperfusion/ischemia in stroke, heart attacks, etc.
08/07/2003US20030149036 Substituted benzothiazole amide derivatives
08/07/2003US20030149035 For therapy and prophylaxis of infections by herpesviruses
08/07/2003US20030149034 Indazoles substituted with1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
08/07/2003US20030149033 For prophylaxis and therapy of cerebrovascular diseases such as cerebral ischemia, stroke, reperfusion damage, brain trauma, edemas, cerebral thrombosis, dementia and Alzheimer's diseass
08/07/2003US20030149030 7-phenyl-benzo [b] thiophen amide derivatives
08/07/2003US20030149026 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc.
08/07/2003US20030149025 Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
08/07/2003US20030149024 For therapy of central nervous system disorders such as diseases and conditions related to sleeping, eating, perceiving pain, controlling body temperature, controlling blood pressure, depression, anxiety, schizophrenia
08/07/2003US20030149023 Novel compounds with analgesic effect
08/07/2003US20030149020 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149019 For therapy or prophylaxis of obesity, type II diabetes, or disorders of the central nervous system
08/07/2003US20030149018 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
08/07/2003US20030149014 Imidazo[4,5-b]-pyridinium-containing cephem compounds having broad antibacterial spectrum activity
08/07/2003US20030149013 Methods of treating bacterial infections in dogs and cats
08/07/2003US20030149012 Vision through photodynamic therapy of the eye
1 ... 5382 5383 5384 5385 5386 5387 5388 5389 5390 5391 5392 5393 5394 5395 5396 5397 5398 5399 5400 5401 5402 ... 7860